Literature DB >> 27031864

Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer.

M Burcu Irmak-Yazicioglu1.   

Abstract

Gastric cancer is a genetically heterogeneous disease that causes cancer-related deaths worldwide. Although many studies on this disease have been performed, the molecular mechanisms of gastric tumorigenesis, invasion, and metastasis have still not been identified. MicroRNAs (miRNAs) are endogenously coded small RNA molecules, 18-25 nucleotides in length, that regulate gene expression at the post-transcriptional level. They are required for physiological activities in the cell, including development, proliferation, differentiation, and apoptosis. Research has now indicated their importance in carcinogenesis, with miRNA profiling revealing differences in the tumor and the normal tissue in several cancers. This difference in the expression pattern might lead to disrupted regulation of genes such as tumor suppressor genes and proto-oncogenes that are involved in cell cycle control, proliferative pathways, apoptosis, and metastasis in gastric carcinogenesis. Genes encoding miRNAs have been characterized as novel proto-oncogenes and tumor-suppressor genes based on findings that these miRNAs control malignant phenotypes. miRNA deregulation promotes cell-cycle progression, confers resistance to apoptosis, and enhances invasiveness and metastasis. Deregulated miRNAs affect the regulation of their target genes. Knowing the targets of miRNAs is of great importance for identifying the molecular mechanisms behind gastric carcinogenesis and forms the focus of this review.
© 2016 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27031864     DOI: 10.1159/000443224

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  11 in total

Review 1.  Treatment Strategies of Gastric Cancer-Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review.

Authors:  Magdalena Tyczyńska; Paweł Kędzierawski; Kaja Karakuła; Jacek Januszewski; Krzysztof Kozak; Monika Sitarz; Alicja Forma
Journal:  J Gastrointest Cancer       Date:  2021-03-24

2.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

3.  Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.

Authors:  Qingshun Meng; Longquan Xiang; Jingwei Fu; Xianqun Chu; Chunlin Wang; Bingzheng Yan
Journal:  Oncotarget       Date:  2017-06-06

4.  miR‑27a‑3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells.

Authors:  Hongxin Chen; Binlin Cai; Kun Liu; Qingquan Hua
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

5.  MiR-874 Inhibits Cell Proliferation, Migration, and Invasion of Glioma Cells and Correlates with Prognosis of Glioma Patients.

Authors:  Yongjuan Li; Xiaoyan Chen; Wei Xue; Junjun Liang; Liang Wang
Journal:  Neuromolecular Med       Date:  2020-08-14       Impact factor: 3.843

6.  miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway.

Authors:  Song Wei; Qing Li; Zheng Li; Linjun Wang; Lei Zhang; Zekuan Xu
Journal:  Oncotarget       Date:  2016-11-15

7.  Release of MicroRNAs into Body Fluids from Ten Organs of Mice Exposed to Cigarette Smoke.

Authors:  Alberto Izzotti; Mariagrazia Longobardi; Sebastiano La Maestra; Rosanna T Micale; Alessandra Pulliero; Anna Camoirano; Marta Geretto; Francesco D'Agostini; Roumen Balansky; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Theranostics       Date:  2018-03-08       Impact factor: 11.556

8.  Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis.

Authors:  Li-Dong Zu; Xing-Chun Peng; Zhi Zeng; Jing-Long Wang; Li-Li Meng; Wei-Wei Shen; Chun-Ting Hu; Ye Yang; Guo-Hui Fu
Journal:  J Exp Clin Cancer Res       Date:  2018-06-04

9.  The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.

Authors:  Jing Zhang; Fanghui Ding; Dan Jiao; Qiaozhi Li; Hong Ma
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Regulatory roles of differentially expressed MicroRNAs in metabolic processes in negative Lens-induced myopia Guinea pigs.

Authors:  Dadong Guo; Meihua Ding; Xiaoli Song; Yuanyuan Sun; Guoping Li; Zonghong Li; Huixia Wei; Jianfeng Wu; Wenjun Jiang; Hongsheng Bi
Journal:  BMC Genomics       Date:  2020-01-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.